𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Intravesical treatment of bladder cancer with recombinant human interferon-β

✍ Scribed by Tadao Niijima; Takashi Umeda; Manabu Kuriyama; Hiroyuki Ohmori; Yohsuke Matsumura; Tomoyasu Tsushima; Toyoko Tanahashi; Jun Yoshimoto; Toshihiko Asahi; Norimasa Ike; Taiichiro Johsen; Noritaka Ishido; Naoki Mitsuhata; Takeshi Uyama; Hiroyoshi Tanaka; Hideo Ueda; Jisaburo Sakatoku; Norio Yamamoto; Kazuo Nagata; Yukitoshi Fujita; Masaaki Morioka; Kazuo Kurokawa; Susumu Kagawa; Tomoyuki Ishibe; Yasutoshi Himeno; Toyofumi Ueda

Publisher
Springer-Verlag
Year
1989
Tongue
English
Weight
567 KB
Volume
30
Category
Article
ISSN
0340-7004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of superficial bladder cancer
Treatment of superficial bladder cancer with intravesical chemotherapy
✍ Robert A. Badalament; Riad N. Farah 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 51 KB 👁 2 views

Proper care of patients with superficial bladder cancer requires the assessment of multiple factors, including an understanding of the natural history of this disease, accurate clinical staging, and the expected efficacy of each drug. The pharmacology of intravesical mytomycin C is discussed in deta

Treatment of patients with disseminated
Treatment of patients with disseminated colorectal cancer with recombinant human alpha2-interferon. Studies on the immune system
✍ Stefan Einhorn; Jerzy Wasserman; Göran Lundell; Henric Blomgren; Björn Cedermark 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 French ⚖ 606 KB

The influence of recombinant human alpha 2-interferon (alpha 2-IFN) therapy on various aspects of the immune system was studied in 18 patients with disseminated colorectal cancer. The IFN was given as continuous (20 X 10(6) units/m2 three times weekly) or intermittent (50 X 10(6) units/m2 daily for

Treatment with human recombinant leukocy
Treatment with human recombinant leukocyte interferons inhibitsin vitroinvasive ability of human lung carcinoma cells
✍ Terrence J. Ravine; Nada Ledinko 📂 Article 📅 1986 🏛 Springer 🌐 English ⚖ 821 KB

The effects of treatment of human lung carcinoma cell line A 549 with recombinant DNA-derived human leukocyte interferons A (rIFN-~A) or D (rIFN-aD), and human lymphoblastoid interferon (Wellferon) on in vitro cell invasion were investigated in a quantitative invasion assay using human amnion. The A